-
Cl-Amidine Trifluoroacetate Salt: PAD4 Inhibition Evidence &
2026-05-16
Cl-Amidine (trifluoroacetate salt) is a potent, selective PAD4 inhibitor with an IC50 of 5.9 μM. It is a critical tool in cancer and rheumatoid arthritis research, enabling precise modulation of histone citrullination and neutrophil extracellular trap formation. This article details its evidence base, biochemical specificity, and application limits.
-
Eltanexor Inhibits XPO1 to Suppress Wnt/β-Catenin in CRC Mod
2026-05-15
This study demonstrates that Eltanexor, a second-generation XPO1 inhibitor, effectively reduces colorectal cancer (CRC) tumorigenesis by modulating the Wnt/β-catenin pathway and suppressing COX-2 expression. The findings highlight XPO1 inhibition as a promising chemopreventive strategy for high-risk CRC populations, with translational implications for both preclinical and clinical research.
-
CGP 55845 Hydrochloride: Optimizing GABAB Antagonist Assays
2026-05-15
Leverage CGP 55845 hydrochloride for targeted, reproducible GABAB receptor antagonist workflows in synaptic transmission research. This guide translates cutting-edge glial-neuronal modulation insights into actionable protocol improvements and troubleshooting strategies for in vitro neuroscience.
-
Adenosine Triphosphate (ATP): Precision Tools for Mitochondr
2026-05-14
Explore how Adenosine Triphosphate (ATP) advances mitochondrial proteostasis research through its dual roles in energy metabolism and post-translational regulation. This in-depth article uniquely connects ATP’s biochemical precision to practical assay design, bridging mechanistic insight with reagent selection.
-
Pioglitazone: PPARγ Agonist for Macrophage Polarization Stud
2026-05-14
Pioglitazone from APExBIO stands out as a robust PPARγ agonist for dissecting immune-metabolic mechanisms in chronic inflammation and metabolic disorder research. Advanced workflows and troubleshooting strategies empower precise modeling of macrophage polarization, insulin resistance, and neuroprotection.
-
Fingolimod (FTY720): S1P Receptor Modulator for Multiple Scl
2026-05-13
Fingolimod (FTY720) is an oral sphingosine-1-phosphate receptor modulator FDA-approved for multiple sclerosis. It inhibits lymphocyte egress, modulates CNS signaling, and demonstrates neuroprotection via BDNF upregulation. APExBIO supplies high-purity Fingolimod (A8548) optimized for research workflows.
-
Streptavidin – Cy5: Precision Biotin Detection for IF & Flow
2026-05-13
Streptavidin – Cy5 enables ultra-sensitive, quantitative biotin detection across immunofluorescence and flow cytometry workflows. Its Cy5 fluorescent dye conjugation delivers high signal-to-noise and multiplexing capacity for demanding cell and tissue assays. Discover protocol enhancements and troubleshooting tips validated in recent cancer research.
-
Synergistic Caspase-8 Activation by Hyperthermia and Cisplat
2026-05-12
The referenced study elucidates how hyperthermia combined with cisplatin uniquely enhances caspase-8 accumulation and activation in cancer cells, driving both apoptosis and pyroptosis. This mechanistic insight advances understanding of programmed cell death and suggests new avenues for optimizing combination cancer therapies.
-
ETS1 Regulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model
2026-05-12
This study identifies ETS1 as a transcriptional regulator that mitigates mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) by modulating the SENP2/HSPA8/FUNDC1 axis. The findings illuminate a new mechanistic pathway for targeted autophagy research in pulmonary disease.
-
Lysis Buffer for Mouse Tail: Optimizing Rapid Genotyping Kit
2026-05-11
Unlock highly efficient mouse genotyping workflows with APExBIO’s lysis buffer, a rapid genotyping kit component purpose-built for maximum DNA integrity. This guide delivers protocol enhancements, troubleshooting expertise, and insights from breakthrough CRC biomarker research to elevate your genetic analysis.
-
Erastin: Precision Ferroptosis Inducer for Cancer Biology Re
2026-05-11
Erastin from APExBIO empowers researchers to dissect ferroptosis mechanisms in RAS/BRAF-mutant tumor cells with reproducibility and selectivity. This guide delivers proven protocol enhancements, troubleshooting strategies, and actionable insights, leveraging peer-reviewed breakthroughs to optimize your ferroptosis research workflows.
-
Elobixibat Hydrate: Applied Protocols for GI and Metabolic R
2026-05-10
Elobixibat hydrate, a highly selective ileal bile acid transporter inhibitor, enables robust modeling of gut motility, metabolic regulation, and advanced bowel preparation protocols. This article details hands-on experimental workflows, comparative clinical insights, and troubleshooting strategies to maximize consistency and translational relevance using APExBIO’s Elobixibat hydrate.
-
Axitinib (AG 013736): Potent VEGFR Inhibitor for Cancer Biol
2026-05-09
Axitinib (AG 013736) is a highly selective, orally bioavailable inhibitor of VEGFR1/2/3, exhibiting sub-nanomolar potency and robust selectivity for angiogenesis inhibition in cancer research. Its validated benchmarks, workflow integration, and product-specific parameters make it a gold-standard tool for VEGF signaling pathway studies.
-
Neurotensin (CAS 39379-15-2): Mechanisms and Benchmarks
2026-05-08
Neurotensin is a 13-amino acid neuropeptide and potent Neurotensin receptor 1 activator. It is widely used for GPCR trafficking mechanism studies and miRNA regulation research in gastrointestinal models. Purity, solubility, and mechanistic benchmarks are well-defined, supporting reproducible biochemical experiments.
-
Machine Learning Unlocks New Senolytics for Cancer Research
2026-05-08
This study demonstrates the use of cost-effective machine learning algorithms to identify new senolytic compounds, significantly accelerating drug discovery for targeting senescent cells. The findings provide a robust framework for integrating computational approaches in cancer and aging research, with potential to inform experimental workflows involving selective EGFR and ErbB2 inhibitors.